ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "fibromyalgia"

  • Abstract Number: 1609 • ACR Convergence 2023

    Associations Between SARS-Cov-2 Infection and Neuropathic Pain in Fibromyalgia Patients: A Cohort Study

    Danilo Perretta1, Daniele Mauro1, flavia riccio1, valentina marino1, emma scoppetta2, Francesco ciccia1 and rosella tirri1, 1University of Campania - Luigi Vanvitelli, Naples, Italy, 2University of Salerno, Salerno, Italy

    Background/Purpose: SARS-CoV-2 infection has been increasingly recognized for its potential neurological manifestations. Fibromyalgia (FM) patients, who already experience neuropathic pain, may be particularly vulnerable to…
  • Abstract Number: 1837 • ACR Convergence 2023

    Depression and Suicide Attempt in Systemic Lupus Erythematosus with and Without Fibromyalgia

    Irakli Tskhakaia1, Pushti Khandwala1 and Irene Tan2, 1Albert Einstein Medical Center Philadelphia, Philadelphia, PA, 2Einstein Medical Center Philadelphia, Bala Cynwyd, PA

    Background/Purpose: Suicide and depression represent a high burden of morbidity and mortality worldwide. It is well known that fibromyalgia (FM) is associated with mood and…
  • Abstract Number: 1610 • ACR Convergence 2023

    Digital Acceptance and Commitment Therapy Improves Fibromyalgia Outcomes: Results from a Pivotal, Multi-center, Randomized Controlled Trial

    Michael Gendreau1, Andrea Chadwick2, Lance McCracken3, David Williams4, Daniel Clauw5, Juan Luciano6, Yifei Dai7, Nicolette Vega8, Zunera Ghalib8, Kristen Guthrie8, Allison Kraus8, Michael Rosenbluth8, Jennifer Zomnir9, Dana Reddy10 and Lesley arnold11, 1Gendreau Consulting, LLC, Poway, CA, 2Department of Anesthesiology, Pain, and Perioperative Medicine, University of Kansas School of Medicine, Kansas City, KS, 3Department of Psychology, Uppsala University, Uppsala, Sweden, 4Chronic Pain and Fatigue Research Center, Department of Anesthesiology, University of Michigan, Ann Arbor, MI, 5Department of Anesthesiology, University of Michigan, Ann Arbor, MI, 6Department of Clinical and Health Psychology, Universitat Autónoma de Barcelona, Barcelona, Spain, 7Swing Therapeutics, Gainesville, FL, 8Swing Therapeutics, San Francisco, CA, 9DelRicht Resesarch, Mckinney, TX, 10Curavit, Scarsdale, NY, 11Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, Cincinnati, OH

    Background/Purpose: Acceptance and Commitment Therapy (ACT), a form of guideline-recommended Cognitive Behavioral Therapy (CBT), has been empirically validated as a non-drug treatment for fibromyalgia (FM).…
  • Abstract Number: 1839 • ACR Convergence 2023

    Value of Small Fiber Neuropathy in Fibromyalgia Patients in a Rheumatological Setting

    Styliani Tsiami1, Elena Enax-Krumova2, Dietrich Sturm3, Matthias Vorgerd2, Bjoern Buehring4, Juergen Braun5 and Xenofon Baraliakos1, 1Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 2Neurologische Klinik Universitätsklinikum Bergmannsheil Bochum, Ruhr-University Bochum, Bochum, Germany, 3Agaplesion Bethesda - Krankenhaus, Wuppertal, Klinik für Neurologie, Wuppertal, Germany, 4Krankenhaus St. Josef, Wuppertal, Klinik für Internistische Rheumatologie, Wuppertal, Germany, 5Ruhr-Universität Bochum and Rheumazentrum Ruhrgebiet, Herne, Germany

    Background/Purpose: Small fiber neuropathy (SFN), a polyneuropathy (PNP) affecting A-delta and C-fibers has been described in patients with fibromyalgia (FM). Different patterns of small fiber…
  • Abstract Number: 1611 • ACR Convergence 2023

    Mitochondrial Structural Alterations in Fibromyalgia – A Pilot Electron Microscopy Study

    Linoy Israel1, Victoria Furer2, Atan Gross1 and Jacob Ablin2, 1Weizmann Institute of Science, Rehovot, Israel, 2Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

    Background/Purpose: Fibromyalgia (FM) is among the most common chronic pain conditions, clinically characterized by widespread pain and fatigue. FM pathogenesis remains unknown, leading to challenges…
  • Abstract Number: 1855 • ACR Convergence 2023

    Using a Whole-population Approach to Help Design More Effective and Efficient Healthcare Services for People with Fibromyalgia

    Gary Macfarlane1, Roxanne Cooksey2, Ernest Choy3 and Rosemary Hollick4, 1Aberdeen Centre for Arthritis and Musculoskeletal Health (Epidemiology Group), University of Aberdeen, Aberdeen, United Kingdom, 2Cardiff University, Cardiff, United Kingdom, 3Section of Rheumatology, Cardiff University, Cardiff, United Kingdom, 4University of Aberdeen, Aberdeen, United Kingdom

    Background/Purpose: A large body of evidence has informed, internationally, management recommendations for people with fibromyalgia. However there are very few studies which have examined how…
  • Abstract Number: 1612 • ACR Convergence 2023

    Design and Validation of a Comparator for Randomized Controlled Trials of a Digital Cognitive Behavioral Therapy

    Michael Gendreau1, Yifei Dai2, Michael Rosenbluth3, David Williams4 and Daniel Clauw5, 1Gendreau Consulting, LLC, Poway, CA, 2Swing Therapeutics, Gainesville, FL, 3Swing Therapeutics, San Francisco, CA, 4Chronic Pain and Fatigue Research Center, Department of Anesthesiology, University of Michigan, Ann Arbor, MI, 5Department of Anesthesiology, University of Michigan, Ann Arbor, MI

    Background/Purpose: The use of a control arm (comparator) in randomized controlled trials (RCTs) is considered the gold standard for trial conduct and interpretation. Choosing an…
  • Abstract Number: 1857 • ACR Convergence 2023

    More Than 50% of Rheumatoid Arthritis (RA) Patients with High or Moderate CDAI (clinical Disease Activity Index) Screen Positive on MDHAQ (multidimensional Health Assessment Questionnaire) Indices for FAST4 (fibromyalgia Assessment Screening Tool) And/or MDS2 (MDHAQ Depression Screen)

    Juan Schmukler and Theodore Pincus, Rush University Medical Center, Chicago, IL

    Background/Purpose: Treat to target in rheumatoid arthritis (RA) suggests escalation of therapy in patients whose scores are high or moderate on a disease activity index…
  • Abstract Number: 1613 • ACR Convergence 2023

    Tetrodotoxin Sensitive Nav1.7 Sodium Channel SCN9A Gene Polymorphism rs6754031(T >G) Is Associated with Fibromyalgia

    Koshy Nithin Thomas, Shivika Guleria, Amita Aggarwal and Able Lawrence, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, India

    Background/Purpose: SCN9A gene encodes a tetrodotoxin sensitive Nav1.7 Sodium channel expressed in dorsal root ganglia, peripheral nerves, olfactory nerves and inner ear. Rare Mutations in…
  • Abstract Number: 2037 • ACR Convergence 2023

    Assessing Risk of Depression in Common Rheumatologic Disorders Using Diagnostic Codes, Survey Scores, and Propensity Score Matching Methodology

    COMFORT ANIM-KORANTENG1, YONG EUN2, Okeoghene Akpoigbe2 and AMANDA SAMMUT2, 1Harlem Hospital Center, New York, NY, 2NYCHH- HARLEM, New York, NY

    Background/Purpose: Many studies have shown that rheumatologic conditions are associated with a higher risk of depression. The two most common methods to detect depression in…
  • Abstract Number: 1614 • ACR Convergence 2023

    Therapy Combining Millimeter Wave-based Neuromodulation with Coaching for the Improvement in Quality of Life of Patients with Fibromyalgia: A Prospective, Multicenter, Randomized, Controlled Trial

    Caroline Maindet1, Anne Dumolard2, Mélanie Veloso2, Mario Barmaki3, Rodrigue Deleens4, Raphaël Gonon-Demoulian5, Alberta Lorenzi-Pernot6, Mireille Michel-Cherqui7, Alain Serrie8, Stanislas Velliet9 and Jean-Luc Bosson2, 1University Hospital Grenoble Alpes, Grenoble, France, 2Grenoble Alpes University Hospital, Grenoble, France, 3Médipôle Lyon Villeurbanne, Lyon, France, 4Rouen University Hospital, Rouen, France, 5Montpellier University Hospital, Montpellier, France, 6Neurology private practice, Mornant, France, 7Foch hospital, Suresnes, France, 8Paris University Hospital, Paris, Guinea, 9Valenciennes hospital, Valenciennes, France

    Background/Purpose: Fibromyalgia is a chronic syndrome with symptoms of moderate to severe intensity, including diffuse pain, fatigue, sleep disturbance, and cognitive impairment. While first-line recommendation…
  • Abstract Number: PP09 • ACR Convergence 2023

    Practicing Mindfulness to Improve Quality of Life

    Vanessa Patino-Lydia, Global Healthy Living Foundation, Hallandale, FL

    Background/Purpose: I’ve been living with symptoms of PSA and fibromyalgia for over 15 years. Four years ago, after flareup that severely impacted my mobility where…
  • Abstract Number: 1629 • ACR Convergence 2023

    Persons with Rheumatoid Arthritis and Long COVID Had Worse Pre-COVID RA Symptoms and Worse Non-RA Symptoms, as Well as Higher Rates of Fibromyalgia Compared with COVID Infected Long COVID Negative

    Kaleb Michaud1, Sofia Pedro2, Shreena Kamlesh Gandhi3 and Frederick Wolfe2, 1University of Nebraska Medical Center, Omaha, NE, 2Forward, The National Databank for Rheumatic Diseases, Wichita, KS, 3Kansas University School of Medicine, Wichita, KS

    Background/Purpose: Long COVID, also known as Post COVID syndrome or postacute sequelae of SARS-CoV-2 infection, refers to the development of persistent or new symptoms lasting…
  • Abstract Number: 1219 • ACR Convergence 2022

    Gender-Related Clinical Profile of Fibromyalgia Patients

    Mark Berman1, Liane banon2, Omer Shlezinger3, Laurence Mangel4, Jacob Ablin1 and Valerie Aloush5, 1Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 2Department of Gastroenterology and Hepatolgy, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 3Internal Medicine F, Tel Aviv, Israel, 4Sackler faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, 5Tel Aviv Medical Center, Tel Aviv, Israel

    Background/Purpose: Fibromyalgia is a chronic pain disorder characterized by widespread pain, fatigue, sleep disturbances, cognitive dysfunction and frequent psychiatric comorbidities. Estimated prevalence of fibromyalgia is…
  • Abstract Number: 1220 • ACR Convergence 2022

    Autonomic Dysfunction in Sjogren’s Disease

    Ardy Fenando1, Jordan Estes1, Maha Mohamad1, Sareena Shah2, John Lee2, Duaa Jabari1, Joshua Baker3 and Ghaith Noaiseh1, 1University of Kansas Medical Center, Kansas City, KS, 2University of Missouri-Kansas City, Kansas City, MO, 3University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Sjogren's Disease (SjD) is a heterogenous autoimmune disease associated with debilitating symptoms. Autonomic dysfunction (AD) is common in SjD and may contribute to symptom…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 25
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology